Menu
GeneBe

19-50271473-C-T

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4BP6BS1BS2

The NM_001145809.2(MYH14):​c.3098C>T​(p.Thr1033Met) variant causes a missense change. The variant allele was found at a frequency of 0.000277 in 1,607,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00029 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:2

Conservation

PhyloP100: 4.64
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.31008965).
BP6
Variant 19-50271473-C-T is Benign according to our data. Variant chr19-50271473-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 228876.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=4, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00029 (422/1455816) while in subpopulation NFE AF= 0.000352 (390/1109230). AF 95% confidence interval is 0.000323. There are 0 homozygotes in gnomad4_exome. There are 189 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 23 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYH14NM_001145809.2 linkuse as main transcriptc.3098C>T p.Thr1033Met missense_variant 25/43 ENST00000642316.2
MYH14NM_001077186.2 linkuse as main transcriptc.2999C>T p.Thr1000Met missense_variant 24/42
MYH14NM_024729.4 linkuse as main transcriptc.2975C>T p.Thr992Met missense_variant 23/41

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYH14ENST00000642316.2 linkuse as main transcriptc.3098C>T p.Thr1033Met missense_variant 25/43 NM_001145809.2 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
151968
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000185
AC:
44
AN:
238122
Hom.:
0
AF XY:
0.000171
AC XY:
22
AN XY:
128988
show subpopulations
Gnomad AFR exome
AF:
0.0000690
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000381
Gnomad NFE exome
AF:
0.000316
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.000290
AC:
422
AN:
1455816
Hom.:
0
Cov.:
32
AF XY:
0.000261
AC XY:
189
AN XY:
723508
show subpopulations
Gnomad4 AFR exome
AF:
0.0000300
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000118
Gnomad4 FIN exome
AF:
0.000414
Gnomad4 NFE exome
AF:
0.000352
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152086
Hom.:
0
Cov.:
31
AF XY:
0.000161
AC XY:
12
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000472
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000244
Hom.:
0
Bravo
AF:
0.000136
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000239
AC:
29

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:5Benign:2
Uncertain significance, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 17, 2017The p.Thr992Met variant (rs201746408) has not been reported in the medical literature and gene specific variation databases. This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.02 percent (identified on 45 out of 266,124 chromosomes) and has been reported to the ClinVar database as a variant of uncertain significance (Variation ID: 228876). The threonine at position 992 is highly conserved considering 7 species (Alamut v2.10) and computational analyses of the effects of the p.Thr992Met variant on protein structure and function provide conflicting results (SIFT: damaging, MutationTaster: disease causing, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Thr992Met variant with certainty. -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJul 20, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH14 protein function. ClinVar contains an entry for this variant (Variation ID: 228876). This variant has not been reported in the literature in individuals affected with MYH14-related conditions. This variant is present in population databases (rs201746408, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 992 of the MYH14 protein (p.Thr992Met). -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2022MYH14: BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 10, 2020- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 02, 2015The p.Thr1033Met variant in MYH14 has not been previously reported in individual s with hearing loss, but has been identified in 20/41758 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s201746408). Computational prediction tools and conservation analysis suggest th at this variant may impact the protein, though this information is not predictiv e enough to determine pathogenicity. In summary, the clinical significance of th e p.Thr1033Met variant is uncertain. -
Autosomal dominant nonsyndromic hearing loss 4A Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.29
CADD
Pathogenic
27
DANN
Uncertain
1.0
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.93
D
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.31
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.043
T
MutationTaster
Benign
0.99
D;D;D;D
PrimateAI
Uncertain
0.63
T
Sift4G
Uncertain
0.0040
D;D;D;.;D;D;D
Polyphen
0.94
P;P;P;D;.;D;P
Vest4
0.54
MVP
0.54
MPC
0.65
ClinPred
0.36
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.050
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201746408; hg19: chr19-50774730; COSMIC: COSV51829975; API